Global Radiopharmaceuticals Market Insights and Forecast to 2027

Global Radiopharmaceuticals Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 Diagnostic Radioisotopes
1.4.3 Therapeutic Radioisotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals Sales Estimates and Forecasts 2016-2027
2.2 Global Radiopharmaceuticals Revenue Estimates and Forecasts 2016-2027
2.3 Global Radiopharmaceuticals Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Radiopharmaceuticals Regions by Sales
2.4.1 Global Top Radiopharmaceuticals Regions by Sales (2016-2021)
2.4.2 Global Top Radiopharmaceuticals Regions by Sales (2022-2027)
2.5 Global Top Radiopharmaceuticals Regions by Revenue
2.5.1 Global Top Radiopharmaceuticals Regions by Revenue (2016-2021)
2.5.2 Global Top Radiopharmaceuticals Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global Top Radiopharmaceuticals Manufacturers by Sales (2016-2021)
3.1.2 Global Top Radiopharmaceuticals Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals Sales in 2020
3.2 Global Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global Top Radiopharmaceuticals Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Radiopharmaceuticals Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals Revenue in 2020
3.3 Global Radiopharmaceuticals Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Radiopharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiopharmaceuticals Sales by Type
4.1.1 Global Radiopharmaceuticals Historical Sales by Type (2016-2021)
4.1.2 Global Radiopharmaceuticals Forecasted Sales by Type (2022-2027)
4.1.3 Global Radiopharmaceuticals Sales Market Share by Type (2016-2027)
4.2 Global Radiopharmaceuticals Revenue by Type
4.2.1 Global Radiopharmaceuticals Historical Revenue by Type (2016-2021)
4.2.2 Global Radiopharmaceuticals Forecasted Revenue by Type (2022-2027)
4.2.3 Global Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
4.3 Global Radiopharmaceuticals Price by Type
4.3.1 Global Radiopharmaceuticals Price by Type (2016-2021)
4.3.2 Global Radiopharmaceuticals Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Radiopharmaceuticals Sales by Application
5.1.1 Global Radiopharmaceuticals Historical Sales by Application (2016-2021)
5.1.2 Global Radiopharmaceuticals Forecasted Sales by Application (2022-2027)
5.1.3 Global Radiopharmaceuticals Sales Market Share by Application (2016-2027)
5.2 Global Radiopharmaceuticals Revenue by Application
5.2.1 Global Radiopharmaceuticals Historical Revenue by Application (2016-2021)
5.2.2 Global Radiopharmaceuticals Forecasted Revenue by Application (2022-2027)
5.2.3 Global Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
5.3 Global Radiopharmaceuticals Price by Application
5.3.1 Global Radiopharmaceuticals Price by Application (2016-2021)
5.3.2 Global Radiopharmaceuticals Price Forecast by Application (2022-2027)
6 North America
6.1 North America Radiopharmaceuticals Market Size by Type
6.1.1 North America Radiopharmaceuticals Sales by Type (2016-2027)
6.1.2 North America Radiopharmaceuticals Revenue by Type (2016-2027)
6.2 North America Radiopharmaceuticals Market Size by Application
6.2.1 North America Radiopharmaceuticals Sales by Application (2016-2027)
6.2.2 North America Radiopharmaceuticals Revenue by Application (2016-2027)
6.3 North America Radiopharmaceuticals Market Size by Country
6.3.1 North America Radiopharmaceuticals Sales by Country (2016-2027)
6.3.2 North America Radiopharmaceuticals Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Radiopharmaceuticals Market Size by Type
7.1.1 Europe Radiopharmaceuticals Sales by Type (2017-2027)
7.1.2 Europe Radiopharmaceuticals Revenue by Type (2017-2027)
7.2 Europe Radiopharmaceuticals Market Size by Application
7.2.1 Europe Radiopharmaceuticals Sales by Application (2017-2027)
7.2.2 Europe Radiopharmaceuticals Revenue by Application (2017-2027)
7.3 Europe Radiopharmaceuticals Market Size by Country
7.3.1 Europe Radiopharmaceuticals Sales by Country (2017-2027)
7.3.2 Europe Radiopharmaceuticals Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals Market Size by Type
8.1.1 Asia Pacific Radiopharmaceuticals Sales by Type (2018-2027)
8.1.2 Asia Pacific Radiopharmaceuticals Revenue by Type (2018-2027)
8.2 Asia Pacific Radiopharmaceuticals Market Size by Application
8.2.1 Asia Pacific Radiopharmaceuticals Sales by Application (2018-2027)
8.2.2 Asia Pacific Radiopharmaceuticals Revenue by Application (2018-2027)
8.3 Asia Pacific Radiopharmaceuticals Market Size by Region
8.3.1 Asia Pacific Radiopharmaceuticals Sales by Region (2018-2027)
8.3.2 Asia Pacific Radiopharmaceuticals Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Radiopharmaceuticals Market Size by Type
9.1.1 Latin America Radiopharmaceuticals Sales by Type (2019-2027)
9.1.2 Latin America Radiopharmaceuticals Revenue by Type (2019-2027)
9.2 Latin America Radiopharmaceuticals Market Size by Application
9.2.1 Latin America Radiopharmaceuticals Sales by Application (2019-2027)
9.2.2 Latin America Radiopharmaceuticals Revenue by Application (2019-2027)
9.3 Latin America Radiopharmaceuticals Market Size by Country
9.3.1 Latin America Radiopharmaceuticals Sales by Country (2019-2027)
9.3.2 Latin America Radiopharmaceuticals Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Radiopharmaceuticals Market Size by Type
6.1.1 Middle East and Africa Radiopharmaceuticals Sales by Type (2016-2027)
6.1.2 Middle East and Africa Radiopharmaceuticals Revenue by Type (2016-2027)
6.2 Middle East and Africa Radiopharmaceuticals Market Size by Application
6.2.1 Middle East and Africa Radiopharmaceuticals Sales by Application (2016-2027)
6.2.2 Middle East and Africa Radiopharmaceuticals Revenue by Application (2016-2027)
6.3 Middle East and Africa Radiopharmaceuticals Market Size by Country
6.3.1 Middle East and Africa Radiopharmaceuticals Sales by Country (2016-2027)
6.3.2 Middle East and Africa Radiopharmaceuticals Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Overview
11.1.3 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bracco Imaging Radiopharmaceuticals Product Description
11.1.5 Bracco Imaging Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Bayer Radiopharmaceuticals Product Description
11.2.5 Bayer Related Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Mallinckrodt Radiopharmaceuticals Product Description
11.3.5 Mallinckrodt Related Developments
11.4 Nordion
11.4.1 Nordion Corporation Information
11.4.2 Nordion Overview
11.4.3 Nordion Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Nordion Radiopharmaceuticals Product Description
11.4.5 Nordion Related Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Corporation Information
11.5.2 Triad Isotopes Overview
11.5.3 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Triad Isotopes Radiopharmaceuticals Product Description
11.5.5 Triad Isotopes Related Developments
11.6 Lantheus
11.6.1 Lantheus Corporation Information
11.6.2 Lantheus Overview
11.6.3 Lantheus Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Lantheus Radiopharmaceuticals Product Description
11.6.5 Lantheus Related Developments
11.7 IBA Group
11.7.1 IBA Group Corporation Information
11.7.2 IBA Group Overview
11.7.3 IBA Group Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 IBA Group Radiopharmaceuticals Product Description
11.7.5 IBA Group Related Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Corporation Information
11.8.2 GE Healthcare Overview
11.8.3 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 GE Healthcare Radiopharmaceuticals Product Description
11.8.5 GE Healthcare Related Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Corporation Information
11.9.2 China Isotope & Radiation Overview
11.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 China Isotope & Radiation Radiopharmaceuticals Product Description
11.9.5 China Isotope & Radiation Related Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Corporation Information
11.10.2 Jubilant Pharma Overview
11.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Jubilant Pharma Radiopharmaceuticals Product Description
11.10.5 Jubilant Pharma Related Developments
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Overview
11.1.3 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bracco Imaging Radiopharmaceuticals Product Description
11.1.5 Bracco Imaging Related Developments
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Corporation Information
11.12.2 Advanced Accelerator Applications Overview
11.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Advanced Accelerator Applications Product Description
11.12.5 Advanced Accelerator Applications Related Developments
11.13 SIEMENS
11.13.1 SIEMENS Corporation Information
11.13.2 SIEMENS Overview
11.13.3 SIEMENS Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 SIEMENS Product Description
11.13.5 SIEMENS Related Developments
11.14 Dongcheng
11.14.1 Dongcheng Corporation Information
11.14.2 Dongcheng Overview
11.14.3 Dongcheng Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Dongcheng Product Description
11.14.5 Dongcheng Related Developments
11.15 Navidea
11.15.1 Navidea Corporation Information
11.15.2 Navidea Overview
11.15.3 Navidea Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Navidea Product Description
11.15.5 Navidea Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Radiopharmaceuticals Value Chain Analysis
12.2 Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiopharmaceuticals Production Mode & Process
12.4 Radiopharmaceuticals Sales and Marketing
12.4.1 Radiopharmaceuticals Sales Channels
12.4.2 Radiopharmaceuticals Distributors
12.5 Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Radiopharmaceuticals Industry Trends
13.2 Radiopharmaceuticals Market Drivers
13.3 Radiopharmaceuticals Market Challenges
13.4 Radiopharmaceuticals Market Restraints
14 Key Findings in The Global Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceuticals Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Diagnostic Radioisotopes
Table 3. Major Manufacturers of Therapeutic Radioisotopes
Table 4. Global Radiopharmaceuticals Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Radiopharmaceuticals Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
Table 7. Global Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 8. Global Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
Table 9. Global Radiopharmaceuticals Sales Market Share by Region (2022-2027)
Table 10. Global Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 12. Global Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Radiopharmaceuticals Revenue Market Share by Region (2022-2027)
Table 14. Global Radiopharmaceuticals Sales by Manufacturers (2016-2021) & (K Dose)
Table 15. Global Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 16. Global Radiopharmaceuticals Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 18. Radiopharmaceuticals Price by Manufacturers 2016-2021 (USD/Dose)
Table 19. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2020)
Table 21. Radiopharmaceuticals Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Radiopharmaceuticals Product Offered
Table 23. Date of Manufacturers Enter into Radiopharmaceuticals Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 26. Global Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 27. Global Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 28. Global Radiopharmaceuticals Sales Share by Type (2022-2027)
Table 29. Global Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 32. Global Radiopharmaceuticals Revenue Share by Type (2022-2027)
Table 33. Radiopharmaceuticals Price by Type (2016-2021) & (USD/Dose)
Table 34. Global Radiopharmaceuticals Price Forecast by Type (2022-2027) & (USD/Dose)
Table 35. Global Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 36. Global Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 37. Global Radiopharmaceuticals Sales Share by Application (2016-2021)
Table 38. Global Radiopharmaceuticals Sales Share by Application (2022-2027)
Table 39. Global Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Radiopharmaceuticals Revenue Share by Application (2016-2021)
Table 42. Global Radiopharmaceuticals Revenue Share by Application (2022-2027)
Table 43. Radiopharmaceuticals Price by Application (2016-2021) & (USD/Dose)
Table 44. Global Radiopharmaceuticals Price Forecast by Application (2022-2027) & (USD/Dose)
Table 45. North America Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 46. North America Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 47. North America Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 50. North America Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 51. North America Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 54. North America Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 55. North America Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 58. Europe Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 59. Europe Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 62. Europe Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 63. Europe Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 66. Europe Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 67. Europe Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 70. Asia Pacific Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 71. Asia Pacific Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 74. Asia Pacific Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 75. Asia Pacific Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)
Table 78. Asia Pacific Radiopharmaceuticals Sales by Region (2022-2027) & (K Dose)
Table 79. Asia Pacific Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Radiopharmaceuticals Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 82. Latin America Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 83. Latin America Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 86. Latin America Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 87. Latin America Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 90. Latin America Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 91. Latin America Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)
Table 94. Middle East and Africa Radiopharmaceuticals Sales by Type (2022-2027) & (K Dose)
Table 95. Middle East and Africa Radiopharmaceuticals Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Radiopharmaceuticals Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)
Table 98. Middle East and Africa Radiopharmaceuticals Sales by Application (2022-2027) & (K Dose)
Table 99. Middle East and Africa Radiopharmaceuticals Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Radiopharmaceuticals Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)
Table 102. Middle East and Africa Radiopharmaceuticals Sales by Country (2022-2027) & (K Dose)
Table 103. Middle East and Africa Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Radiopharmaceuticals Revenue by Country (2022-2027) & (US$ Million)
Table 105. Bracco Imaging Corporation Information
Table 106. Bracco Imaging Description and Major Businesses
Table 107. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 108. Bracco Imaging Radiopharmaceuticals Product
Table 109. Bracco Imaging Recent Developments
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Bayer Radiopharmaceuticals Product
Table 114. Bayer Recent Developments
Table 115. Mallinckrodt Corporation Information
Table 116. Mallinckrodt Description and Major Businesses
Table 117. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Mallinckrodt Radiopharmaceuticals Product
Table 119. Mallinckrodt Recent Developments
Table 120. Nordion Corporation Information
Table 121. Nordion Description and Major Businesses
Table 122. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Nordion Radiopharmaceuticals Product
Table 124. Nordion Recent Developments
Table 125. Triad Isotopes Corporation Information
Table 126. Triad Isotopes Description and Major Businesses
Table 127. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. Triad Isotopes Radiopharmaceuticals Product
Table 129. Triad Isotopes Recent Developments
Table 130. Lantheus Corporation Information
Table 131. Lantheus Description and Major Businesses
Table 132. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Lantheus Radiopharmaceuticals Product
Table 134. Lantheus Recent Developments
Table 135. IBA Group Corporation Information
Table 136. IBA Group Description and Major Businesses
Table 137. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. IBA Group Radiopharmaceuticals Product
Table 139. IBA Group Recent Developments
Table 140. GE Healthcare Corporation Information
Table 141. GE Healthcare Description and Major Businesses
Table 142. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. GE Healthcare Radiopharmaceuticals Product
Table 144. GE Healthcare Recent Developments
Table 145. China Isotope & Radiation Corporation Information
Table 146. China Isotope & Radiation Description and Major Businesses
Table 147. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 148. China Isotope & Radiation Radiopharmaceuticals Product
Table 149. China Isotope & Radiation Recent Developments
Table 150. Jubilant Pharma Corporation Information
Table 151. Jubilant Pharma Description and Major Businesses
Table 152. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 153. Jubilant Pharma Radiopharmaceuticals Product
Table 154. Jubilant Pharma Recent Developments
Table 155. Eli Lilly Corporation Information
Table 156. Eli Lilly Description and Major Businesses
Table 157. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Eli Lilly Radiopharmaceuticals Product
Table 159. Eli Lilly Recent Developments
Table 160. Advanced Accelerator Applications Corporation Information
Table 161. Advanced Accelerator Applications Description and Major Businesses
Table 162. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Advanced Accelerator Applications Radiopharmaceuticals Product
Table 164. Advanced Accelerator Applications Recent Developments
Table 165. SIEMENS Corporation Information
Table 166. SIEMENS Description and Major Businesses
Table 167. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. SIEMENS Radiopharmaceuticals Product
Table 169. SIEMENS Recent Developments
Table 170. Dongcheng Corporation Information
Table 171. Dongcheng Description and Major Businesses
Table 172. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 173. Dongcheng Radiopharmaceuticals Product
Table 174. Dongcheng Recent Developments
Table 175. Navidea Corporation Information
Table 176. Navidea Description and Major Businesses
Table 177. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 178. Navidea Radiopharmaceuticals Product
Table 179. Navidea Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Radiopharmaceuticals Distributors List
Table 183. Radiopharmaceuticals Customers List
Table 184. Radiopharmaceuticals Market Trends
Table 185. Radiopharmaceuticals Market Drivers
Table 186. Radiopharmaceuticals Market Challenges
Table 187. Radiopharmaceuticals Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals Product Picture
Figure 2. Global Radiopharmaceuticals Market Share by Type in 2020 & 2027
Figure 3. Diagnostic Radioisotopes Product Picture
Figure 4. Therapeutic Radioisotopes Product Picture
Figure 5. Global Radiopharmaceuticals Sales Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Cardiology
Figure 8. Other
Figure 9. Radiopharmaceuticals Report Years Considered
Figure 10. Global Radiopharmaceuticals Sales 2016-2027 (K Dose)
Figure 11. Global Radiopharmaceuticals Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Radiopharmaceuticals Revenue 2016-2027 (US$ Million)
Figure 13. Global Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 15. Global Radiopharmaceuticals Sales Market Share by Region (2022-2027)
Figure 16. North America Radiopharmaceuticals Sales YoY (2016-2027) & (K Dose)
Figure 17. North America Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Radiopharmaceuticals Sales YoY (2016-2027) & (K Dose)
Figure 19. Europe Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Radiopharmaceuticals Sales YoY (2016-2027) & (K Dose)
Figure 21. Asia-Pacific Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Radiopharmaceuticals Sales YoY (2016-2027) & (K Dose)
Figure 23. Latin America Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Radiopharmaceuticals Sales YoY (2016-2027) & (K Dose)
Figure 25. Middle East & Africa Radiopharmaceuticals Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Radiopharmaceuticals Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Radiopharmaceuticals Revenue in 2020
Figure 28. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Radiopharmaceuticals Sales Market Share by Type (2016-2027)
Figure 30. Global Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
Figure 31. Global Radiopharmaceuticals Sales Market Share by Application (2016-2027)
Figure 32. Global Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
Figure 33. North America Radiopharmaceuticals Sales Market Share by Type (2016-2027)
Figure 34. North America Radiopharmaceuticals Revenue Market Share by Type (2016-2027)
Figure 35. North America Radiopharmaceuticals Sales Market Share by Application (2016-2027)
Figure 36. North America Radiopharmaceuticals Revenue Market Share by Application (2016-2027)
Figure 37. North America Radiopharmaceuticals Sales Share by Country (2016-2027)
Figure 38. North America Radiopharmaceuticals Revenue Share by Country (2016-2027)
Figure 39. U.S. Radiopharmaceuticals Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Radioph

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Radiopharmaceutical Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......

Global Radiopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......

Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......

Global Radiation Dose Management Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......

Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......

Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124

Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......

Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs